Quinine in severe falciparum malaria: evidence of declining efficacy in Thailand
- PMID: 7974679
- DOI: 10.1016/0035-9203(94)90102-3
Quinine in severe falciparum malaria: evidence of declining efficacy in Thailand
Abstract
Between 1981 and 1992, 196 Thai adults with severe falciparum malaria were treated with a quinine loading dose regimen. Nineteen patients died (10%) and 6 developed late hypoglycaemia. There was no serious cardiovascular or nervous system toxicity. Although there was no evidence of high grade resistance, and no change in the mortality rate, in recent years an increasing proportion of patients had a delayed clinical and parasitological response to treatment. Since 1988, 78% (29/37) of patients with cerebral malaria were unconscious for > 72 h compared with 41% (11/27) between 1981 and 1987 (P = 0.002). In the past 2 years parasite clearance times have exceeded 96 h in 33% (26/78) of patients compared with 14% (15/102) previously (P = 0.006). Quinine remains an effective treatment for severe multi-drug resistant falciparum malaria in this area, but there is now evidence of a decline in the immediate therapeutic response, and its efficacy will need close monitoring as resistance increases further.
Similar articles
-
Comparison of oral artesunate and quinine plus tetracycline in acute uncomplicated falciparum malaria.Bull World Health Organ. 1994;72(2):233-8. Bull World Health Organ. 1994. PMID: 8205643 Free PMC article. Clinical Trial.
-
A randomized open label clinical trial to compare the efficacy and safety of intravenous quinine followed by oral malarone vs. intravenous quinine followed by oral quinine in the treatment of severe malaria.J Trop Pediatr. 2005 Feb;51(1):17-24. doi: 10.1093/tropej/fmh069. Epub 2004 Dec 15. J Trop Pediatr. 2005. PMID: 15601653 Clinical Trial.
-
Efficacy and safety of quinine loading dose in patients with severe falciparum malaria at a tertiary care hospital in Pakistan.J Pak Med Assoc. 2011 Jan;61(1):27-31. J Pak Med Assoc. 2011. PMID: 22368898
-
Artesunate, artemether or quinine in severe Plasmodium falciparum malaria?Expert Rev Anti Infect Ther. 2007 Apr;5(2):199-204. doi: 10.1586/14787210.5.2.199. Expert Rev Anti Infect Ther. 2007. PMID: 17402835 Review.
-
The 1996 Runme Shaw Memorial Lecture: malaria--past, present and future.Ann Acad Med Singap. 1997 May;26(3):380-7. Ann Acad Med Singap. 1997. PMID: 9285035 Review.
Cited by
-
In vitro activities of quinine and other antimalarials and pfnhe polymorphisms in Plasmodium isolates from Kenya.Antimicrob Agents Chemother. 2010 Aug;54(8):3302-7. doi: 10.1128/AAC.00325-10. Epub 2010 Jun 1. Antimicrob Agents Chemother. 2010. PMID: 20516285 Free PMC article.
-
Plasmodium falciparum Na+/H+ exchanger (pfnhe-1) genetic polymorphism in Indian Ocean malaria-endemic areas.Am J Trop Med Hyg. 2013 Jan;88(1):37-42. doi: 10.4269/ajtmh.2012.12-0359. Epub 2012 Dec 3. Am J Trop Med Hyg. 2013. PMID: 23208889 Free PMC article.
-
Polymorphisms of the pfmdr1 but not the pfnhe-1 gene is associated with in vitro quinine sensitivity in Thai isolates of Plasmodium falciparum.Malar J. 2012 Jan 5;11:7. doi: 10.1186/1475-2875-11-7. Malar J. 2012. PMID: 22221394 Free PMC article.
-
Efficacy of Pyrimethamine/Sulfadoxine versus Chloroquine for the Treatment of Uncomplicated Falciparum Malaria in Children Aged Under 5 Years.Iran J Parasitol. 2013 Jan;8(1):1-17. Iran J Parasitol. 2013. PMID: 23682255 Free PMC article.
-
In vitro susceptibility of Plasmodium falciparum to monodesethylamodiaquine, quinine, mefloquine and halofantrine in Abidjan (Côte d'Ivoire).Afr Health Sci. 2010 Jun;10(2):111-6. Afr Health Sci. 2010. PMID: 21326960 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous